ACR Highlights… ACR Convergence 2025 Highlights – Spondyloarthritis 24 Nov 202513 Dec 2025 The Assessments in Spondyloarthritis International Society (ASAS) and Spondyloarthritis Research and Treatment Network (SPARTAN) Revised Classification Criteria for Axial Spondyloarthritis: Development and Validation in the Classification of Axial SpA Inception…
ACR Highlights… ACR Convergence 2025 Highlights- Vasculitis 24 Nov 2025 MEthotrexate versus TOcilizumab for treatment of Giant cell Arteritis (METOGiA trial): a multicenter, randomized, controlled trial Abstract format and assignment number: Oral presentation 0891 Presenting author: M Samson (France) Date: Monday…
ACR Highlights… ACR Convergence 2025 Highlights- Paediatric rheumatology 24 Nov 2025 Efficacy of Tumor Necrosis Factor Inhibitors in Children Diagnosed With Non-Systemic Juvenile Idiopathic Arthritis <2 Years Old Using The Childhood Arthritis and Rheumatology Research Alliance Registry Abstract format and assignment…
ACR Highlights… ACR Convergence 2025 Highlights- Rheumatoid Arthritis 24 Nov 2025 A Phase 1 Study of Autologous CAR-Treg Cells in Refractory Rheumatoid Arthritis: Interim Report of Safety and Efficacy Abstract format and assignment number: Late-breaking abstract LB23 Presenting author: Kohler Minna…
ACR Highlights… ACR Convergence 2025 Highlights- Basic and Translational Research 24 Nov 2025 Longitudinal peripheral blood multi-omic profiling in at-risk individuals uncovers immune signatures and predictive models for future rheumatoid arthritis conversion Abstract format and assignment number: Oral presentation 0774 Presenting author: J.…
ACR Highlights… ACR Convergence 2025 Highlights- Connective Tissue Diseases 24 Nov 2025 Redefining When to Biopsy the Kidney in Patients with SLE Abstract format and assignment number: Oral presentation 0772 Presenting author: M Petri (USA) Date: Sunday 26th October 2025 Lupus nephritis is…
ACR Highlights… ACR Convergence 2025 Highlights- Non inflammatory Rheumatic Diseases (Osteoarthritis, Osteoporosis and Metabolic bone disease, etc.) 24 Nov 2025 Romosozumab as a Safe Bone-Forming Treatment for Elderly Patients with Established Cardiovascular Risk Factors Poster presentation: POS 0341 Date: Sunday, 26th October 2025 Presenting author: D. Ramos Castro (Spain) This…
ACR Highlights… ACR Convergence 2025 Highlights- Other inflammatory arthritides (such as CPPD and gout) and autoinflammatory diseases 24 Nov 2025 Development of a Disease Activity Index for the Assessment of VEXAS Syndrome (VEXAS-DAI) Abstract format and assignment number: Oral presentation 0777 Date: Sunday, 26th October 2025 Presenting author: M. Koster…
ACR Highlights… Post ACR Convergence 2025 Mentor-Mentee Meetings 15 Oct 2025 Link for registration: https://eularit.atlassian.net/helpcenter/communities/portal/335/group/340/create/2502 EMEUNET Peer Mentoring Sub-Committee
ACR Highlights… ACR Convergence 2024 Highlights- Rheumatoid Arthritis: Clinical (therapeutic) 19 Dec 202419 Dec 2024 Efficacy, Safety, Pharmacokinetics of Anti-CD40 Antibody Abiprubart in Patients with Rheumatoid Arthritis: A Phase 2, Randomized, Placebo-Controlled 12-week-treatment Proof-of-Concept Study Abstract format and assignment number: Oral presentation 1678 Presenting author:…